Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05814822 · ClinicalTrials.gov registry record · NA

Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use

A NA study of Insomnia, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05814822 is a NA study of Insomnia that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 200 participants, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05814822, a NA study of Insomnia, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study will compare the efficacy of telemedicine-delivered cognitive behavioral therapy for insomnia tailored for people using cannabis for sleep (CBTi-CB-TM) to telemedicine-delivered sleep hygiene education (SHE-TM) on sleep, cannabis use, and daytime functioning. We will also evaluate the effects of CBTi-CB-TM on fundamental sleep regulatory system - homeostatic sleep drive - and its association with clinical outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM)
  • BEHAVIORAL Sleep Hygiene Education (SHE-TM)

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-06-01
Est. Completion 2027-08-31
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05814822

The ClinicalTrials.gov registry entry for NCT05814822 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (18% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM) is the first listed.

NCT05814822 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05814822 about?

NCT05814822 is a clinical study titled "Targeting Insomnia to Improve Outcomes in Adults With Problematic Cannabis Use". This study will compare the efficacy of telemedicine-delivered cognitive behavioral therapy for insomnia tailored for people using cannabis for sleep (CBTi-CB-TM) to telemedicine-delivered sleep hygiene education (SHE-TM) on sleep, cannabis use, and daytime functioning. We will also evaluate the eff...

What is the current status of trial NCT05814822?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-06-01. Estimated completion is 2027-08-31.

What conditions does trial NCT05814822 study?

This clinical trial studies the following conditions: Insomnia.

What interventions are being tested in trial NCT05814822?

The interventions under investigation include: Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM) (BEHAVIORAL), Sleep Hygiene Education (SHE-TM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05814822?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05814822 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.